PropertyValue
?:abstract
  • Coagulation dysfunction and inflammatory status were compared between diabetic and non-diabetic COVID-19 patients. The standardized mean difference (SMD) and its 95% confidence interval (CI) was computed for the difference of inflammatory and hypercoagulability markers. The levels of serum ferritin (standardized mean difference-SMD: 0.47, CI 0.17–0.77, p = 0.002), C-reactive protein (SMD = 0.53, CI 0.20–0.86, p = 0.002), interleukin-6 (SMD = 0.31, CI 0.09–0.52, p = 0.005), fibrinogen (SMD = 0.31, CI 0.09–0.54, p = 0.007) and D-dimers (SMD = 0.54, CI 0.16–0.91, p = 0.005) were significantly higher in diabetic COVID-19 cases as compared to non-diabetic COVID-19 patients, suggesting more susceptibility of diabetic COVID-19 patients to coagulation dysfunction and inflammatory storm.
?:creator
?:doi
  • 10.1007/s11239-020-02270-w
?:doi
?:journal
  • J_Thromb_Thrombolysis
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/085e30fecfca75c2e64d4993e9f714101c3daab3.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7474490.xml.json
?:pmcid
?:pmid
?:pmid
  • 32889620.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19
?:type
?:year
  • 2020-09-05

Metadata

Anon_0  
expand all